335
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

DEGRADATION STUDIES OF HIGHLY POTENT AND LIFE THREATENING HUMAN BIRTH DEFECT DRUG—LENALIDOMIDE BY HPLC AND LC-MS

, , , &
Pages 654-679 | Published online: 01 Mar 2010
 

Abstract

Due to the potential toxicity of lenalidomide, a highly potent and severe life threatening human birth defect, a lot of precaution should to be taken in handling such kind of drugs.

Lenalidomide drug-excipient blend from the capsule pharmaceutical dosage form was subjected to different ICH prescribed stress conditions of thermal stress, pH hydrolysis, oxidation and photolysis. The drug was found to be stable only at photolysis and thermal stress, while it was extremely susceptible to other stressing conditions especially it showed extensive degradation under alkali conditions. For establishment of stability-indicating method, the rate of degradation in solutions in which different degradation products were formed were monitored at different time intervals, by using different concentrations of stressing reagents, and the separations was optimized by varying the LC conditions.

An acceptable separation was achieved through a multi-step gradient elution using an ACE® C18, 150 × 4.6 mm i.d, 3 μm, stainless steel analytical column and a mobile phase comprising of 0.01 M phosphate buffer (pH, 2.0 ± 0.1) as mobile phase-A, and a mixture of water and acetonitrile in the ratio of 200:800 (v/v) as mobile phase-B, with a flow rate and detection wavelength being 1.0 mL min−1 and 220 nm respectively. The major degradation products appeared at relative retention times (RRT) of 0.75, 0.86, 0.96, 1.33, 1.52, 1.99, 2.04, 2.62 and 2.66 respectively.

ACKNOWLEDGMENTS

The authors wish to thank the management of Dr. Reddy's group for supporting this work. We would also like to thank our colleagues, Professor's V. Suryanarayan Rao and L.K. Ravindranath for their constant encouragement and guidance.

Notes

Where, ND represent Not detected at that corresponding RRT and degradation condition.

αSpiked concentration.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.